Emil List Larsen
-
- Diabetes Treatment and Management 5
- Nephrology top 5%
-
- Pancreatic function and diabetes 4
-
- Diet and metabolism studies 5
- Adipose Tissue and Metabolism 4
-
- DNA Repair Mechanisms 4
- Metabolism, Diabetes, and Cancer 4
-
- Folate and B Vitamins Research 4
-
- Muscle metabolism and nutrition 3
- Co-authors
- Henrik E. PoulsenAllan WeimannDaniël H. van RaalteJaap A. JolesMark M. SmitsMarcel H.A. MuskietLennart TonneijckA.H. Jan Danser
- Journals
- Free Radical Biology and Medicine (7 papers)Scandinavian Journal of Clinical and Laboratory Investigation (2 papers)Scandinavian Journal of Gastroenterology (2 papers)
- Partner nations
- DenmarkGermanyUnited States
In The Last Decade
Emil List Larsen
32 papers receiving 552 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Endocrinology, Diabetes and Metabolism 292
- Nephrology 93
- Clinical Biochemistry 33
- Surgery 182
- Physiology 80
Countries citing papers authored by Emil List Larsen
This map shows the geographic impact of Emil List Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil List Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil List Larsen more than expected).
Fields of papers citing papers by Emil List Larsen
This network shows the impact of papers produced by Emil List Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil List Larsen. The network helps show where Emil List Larsen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emil List Larsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 15 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 20 | |
| 12 | 2020 | 11 | |
| 13 | 2020 | 18 | |
| 14 | The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trialbreakdown → | 2019 | 253 |
| 15 | 2019 | 38 | |
| 16 | 2019 | 26 | |
| 17 | 2019 | 4 | |
| 18 | 2018 | 14 | |
| 19 | 1991 | 9 | |
| 20 | 1969 | 22 |
About Emil List Larsen
Emil List Larsen is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry and Gastroenterology, having authored 32 papers that have together received 566 indexed citations. Recurring topics across this work include Diet and metabolism studies (5 papers), Diabetes Treatment and Management (5 papers), DNA Repair Mechanisms (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Adipose Tissue and Metabolism (4 papers), Folate and B Vitamins Research (4 papers), Pancreatic function and diabetes (4 papers) and Muscle metabolism and nutrition (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (292 citations), Nephrology (93 citations) and Clinical Biochemistry (33 citations). Emil List Larsen has collaborated with scholars based in Denmark, Germany and United States. Frequent co-authors include Henrik E. Poulsen, Allan Weimann, Daniël H. van Raalte, Jaap A. Joles, Mark M. Smits, Marcel H.A. Muskiet, Lennart Tonneijck, A.H. Jan Danser, Ewout J. Hoorn and Erik J.M. van Bommel. Their work appears in journals such as Free Radical Biology and Medicine, Scandinavian Journal of Clinical and Laboratory Investigation, Scandinavian Journal of Gastroenterology, Scientific Reports and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.